Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04624165 · ClinicalTrials.gov registry record
Patient Perspective of Telemedicine in Gynecology Oncology
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 116
- Enrollment target
NCT04624165: Completed study, sponsored by TriHealth.
NCT04624165 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04624165 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
Research question: do patients in a gynecologic oncology practice value the use of telemedicine as an adjunct to in-person visits and in what circumstances might patients not find these visits to be sufficient?
Primary Outcome
Patient's perspective on telemedicine on a Likert Scale
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2022-10-24 |
What the finished NCT04624165 record still lists
NCT04624165 is an observational study that tracks outcomes without assigning an intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT04624165 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04624165 about?
NCT04624165 is a clinical study titled "Patient Perspective of Telemedicine in Gynecology Oncology". Research question: do patients in a gynecologic oncology practice value the use of telemedicine as an adjunct to in-person visits and in what circumstances might patients not find these visits to be sufficient?
What is the current status of trial NCT04624165?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2021-01-21. Estimated completion is 2022-10-24.
What interventions are being tested in trial NCT04624165?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT04624165?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI